COVID-19

Noa C Harriott1,2,3, Amy L Ryan1,2,3

  • 1Hastings Center for Pulmonary Research, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Southern California, Los Angeles CA 90033, USA.

Heliyon
|January 1, 2024
PubMed
概括

这项研究确定了新的蛋白质生物标志物,包括与严重的COVID-19相关的美索林 (MSLN). 早期的T细胞反应对于较轻的疾病来说似乎至关重要,这表明SARS-CoV-2感染的新疗法标.